A detailed history of Atom Investors LP transactions in Incyte Corp stock. As of the latest transaction made, Atom Investors LP holds 4,691 shares of INCY stock, worth $327,431. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,691
Previous 7,341 36.1%
Holding current value
$327,431
Previous $445,000 30.34%
% of portfolio
0.03%
Previous 0.05%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $151,924 - $181,816
-2,650 Reduced 36.1%
4,691 $310,000
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $114,643 - $142,800
-2,240 Reduced 23.38%
7,341 $445,000
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $541,805 - $637,998
9,581 New
9,581 $545,000
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $356,383 - $406,722
6,169 New
6,169 $356,000
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $380,171 - $458,667
-5,171 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $3.37 Million - $4.68 Million
-53,078 Reduced 91.12%
5,171 $445,000
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $3.41 Million - $4.07 Million
58,249 New
58,249 $3.7 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.